Comparision of coagulation profile trends in case of liver cirrhosis with HCC versus cirrhosis without HCC: Analysis of 150 cases in a tertiary health care

Aarti Tyagi, Anjali Gupta
{"title":"Comparision of coagulation profile trends in case of liver cirrhosis with HCC versus cirrhosis without HCC: Analysis of 150 cases in a tertiary health care","authors":"Aarti Tyagi, Anjali Gupta","doi":"10.18231/j.jdpo.2023.049","DOIUrl":null,"url":null,"abstract":"The physiology of haemostasis and blood coagulation is intimately linked to the hepatic function. Liver disorders can be associated with deranged coagulation profile, thrombocytopenia, and dysfibrinogenemia. In hepatocellular injury, both quantitative and qualitative abnormalities in coagulation factors are often seen. Hepatocellular carcinoma (HCC), peculiar as both cancer and liver cirrhosis to dismay the haemostatic balance towards a prothrombotic state. Our study aims to assess the hemostatic changes and the comparision of coagulation profile trends that occur in cases of liver cirrhosis with HCC versus cirrhosis without HCC: The present study is the hospital based cross-sectional study in a tertiary care centre, New Delhi. A maximum 150 cases of liver cirrhosis with and without hepatocellular carcinoma (HCC) studied from Dec 2017 to Nov 2019 and analysed for parameters related to coagulation i.e. prothrombin time (PT/INR), fibrinogen level and platelet count 1 day prior to the liver transplant. Statistical analysis used: Statistical analysis was done using SPSS 20.0. Comparisons between groups frequencies were made using Chi-square test. P< 0.05 was considered as significant.: Prothrombin time was found to be increased in all the cirrhotic patients (both with and without HCC). Decrease in the level of fibrinogen was observed in 90 % cases of cirrhosis with HCC and 80% of cases of cirrhosis without HCC. Platelet count were almost in normal range among majority of the cirrhosis cases both with and without HCC (86.0% and 75.0% respectively).No significant difference was observed in prothrombin time, fibrinogen level and platelet count among the cases with and without hepatocellular carcinoma (p>0.05).: All the cases showed haemostatic abnormalities in the form of hypofibrinogenemia and increase PT/INR. There is no significant difference in the coagulation profile in cases of cirrhosis with HCC in comparison to cases of cirrhosis without HCC.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IP Journal of Diagnostic Pathology and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.jdpo.2023.049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The physiology of haemostasis and blood coagulation is intimately linked to the hepatic function. Liver disorders can be associated with deranged coagulation profile, thrombocytopenia, and dysfibrinogenemia. In hepatocellular injury, both quantitative and qualitative abnormalities in coagulation factors are often seen. Hepatocellular carcinoma (HCC), peculiar as both cancer and liver cirrhosis to dismay the haemostatic balance towards a prothrombotic state. Our study aims to assess the hemostatic changes and the comparision of coagulation profile trends that occur in cases of liver cirrhosis with HCC versus cirrhosis without HCC: The present study is the hospital based cross-sectional study in a tertiary care centre, New Delhi. A maximum 150 cases of liver cirrhosis with and without hepatocellular carcinoma (HCC) studied from Dec 2017 to Nov 2019 and analysed for parameters related to coagulation i.e. prothrombin time (PT/INR), fibrinogen level and platelet count 1 day prior to the liver transplant. Statistical analysis used: Statistical analysis was done using SPSS 20.0. Comparisons between groups frequencies were made using Chi-square test. P< 0.05 was considered as significant.: Prothrombin time was found to be increased in all the cirrhotic patients (both with and without HCC). Decrease in the level of fibrinogen was observed in 90 % cases of cirrhosis with HCC and 80% of cases of cirrhosis without HCC. Platelet count were almost in normal range among majority of the cirrhosis cases both with and without HCC (86.0% and 75.0% respectively).No significant difference was observed in prothrombin time, fibrinogen level and platelet count among the cases with and without hepatocellular carcinoma (p>0.05).: All the cases showed haemostatic abnormalities in the form of hypofibrinogenemia and increase PT/INR. There is no significant difference in the coagulation profile in cases of cirrhosis with HCC in comparison to cases of cirrhosis without HCC.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伴有 HCC 的肝硬化与不伴有 HCC 的肝硬化的凝血曲线趋势比较:对一家三级医疗机构150个病例的分析
止血和凝血生理与肝功能密切相关。肝脏疾病可导致凝血功能紊乱、血小板减少和纤维蛋白原血症。在肝细胞损伤中,凝血因子的定量和定性异常经常出现。肝细胞癌(HCC)与癌症和肝硬化一样,会破坏止血平衡,使其处于促血栓形成状态。我们的研究旨在评估伴有 HCC 的肝硬化病例与不伴有 HCC 的肝硬化病例的止血变化和凝血谱趋势比较:本研究是在新德里一家三级医疗中心进行的基于医院的横断面研究。从 2017 年 12 月至 2019 年 11 月,最多研究了 150 例有肝细胞癌(HCC)和无肝细胞癌(HCC)的肝硬化病例,并分析了肝移植前 1 天的凝血相关参数,即凝血酶原时间(PT/INR)、纤维蛋白原水平和血小板计数。统计分析使用 SPSS 20.0 进行统计分析。组间频率比较采用卡方检验。P<0.05为差异显著:所有肝硬化患者(无论是否患有 HCC)的凝血酶原时间均延长。在 90% 有 HCC 的肝硬化病例和 80% 无 HCC 的肝硬化病例中观察到纤维蛋白原水平下降。有肝细胞癌和没有肝细胞癌的肝硬化病例中,血小板计数几乎都在正常范围内(分别为 86.0% 和 75.0%):所有病例都出现了低纤维蛋白原血症和 PT/INR 增高的止血异常。与无肝细胞癌的肝硬化病例相比,有肝细胞癌的肝硬化病例的凝血谱无明显差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparision of coagulation profile trends in case of liver cirrhosis with HCC versus cirrhosis without HCC: Analysis of 150 cases in a tertiary health care Stomatological complications and comprehensive oral care of post-menopausal patients undergoing breast cancer treatment The need for standardized dietary guidelines for cancer patients - with review of literature from governing bodies Multiple-lesion, non-familial basal cell carcinoma-An interesting oddity Anterior mediastinal schwannoma: A rare case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1